• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪乳预处理对离体灌流心脏内皮功能障碍模型的心肌保护作用持续存在。

Cardioprotection by Preconditioning with Intralipid Is Sustained in a Model of Endothelial Dysfunction for Isolated-Perfused Hearts.

机构信息

Department of Anesthesiology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany.

Institute for Cardiovascular Physiology, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany.

出版信息

Int J Mol Sci. 2024 Oct 12;25(20):10975. doi: 10.3390/ijms252010975.

DOI:10.3390/ijms252010975
PMID:39456757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11507275/
Abstract

Endothelial dysfunction (ED) is closely associated with most cardiovascular diseases. Experimental models are needed to analyze the potential impact of ED on cardioprotection in constant pressure Langendorff systems (CPLS). One cardioprotective strategy against ischemia/reperfusion injury (I/RI) is conditioning with the lipid emulsion Intralipid (IL). Whether ED modulates the cardioprotective effect of IL remains unknown. The aim of the study was to transfer a protocol using a constant flow Langendorff system for the induction of ED into a CPLS, without the loss of smooth muscle cell functionality, and to analyze the cardioprotective effect of IL against I/RI under ED. In isolated hearts of male Wistar rats, ED was induced by 10 min perfusion of a Krebs-Henseleit buffer containing 60 mM KCl (K+), and the vasodilatory response to the vasodilators histamine (endothelial-dependent) and sodium-nitroprusside (SNP, endothelial-independent) was measured. A CPLS was employed to determine cardioprotection of pre- or postconditioning with 1% IL against I/RI. The constant flow perfusion of K+ reduced endothelial response to histamine but not to SNP, indicating reduced vasodilatory functionality of endothelial cells but not smooth muscle cells. Preconditioning with IL reduced infarct size and improved cardiac function while postconditioning with IL had no effect. The induction of ED neither influenced infarct size nor affected the cardioprotective effect by preconditioning with IL. This protocol allows for studies of cardioprotective strategies under ED in CLPS. The protection by preconditioning with IL seems to be mediated independently of a functional endothelium.

摘要

内皮功能障碍 (ED) 与大多数心血管疾病密切相关。需要实验模型来分析 ED 对恒压 Langendorff 系统 (CPLS) 中心脏保护的潜在影响。一种针对缺血/再灌注损伤 (I/RI) 的心脏保护策略是使用脂质乳剂 Intralipid (IL) 进行预处理。ED 是否调节 IL 的心脏保护作用尚不清楚。本研究的目的是将使用恒流 Langendorff 系统诱导 ED 的方案转移到 CPLS 中,同时不丧失平滑肌细胞功能,并分析 ED 下 IL 对 I/RI 的心脏保护作用。在雄性 Wistar 大鼠的离体心脏中,通过灌注含有 60mM KCl (K+) 的 Krebs-Henseleit 缓冲液 10 分钟来诱导 ED,并测量血管扩张剂组胺 (内皮依赖性) 和硝普钠 (SNP,内皮非依赖性) 的血管扩张反应。采用 CPLS 来确定 1%IL 对 I/RI 的预处理或后处理的心脏保护作用。K+ 的恒流灌注降低了内皮对组胺的反应,但对 SNP 没有影响,表明内皮细胞的血管扩张功能降低,但平滑肌细胞没有。IL 的预处理可减少梗死面积并改善心功能,而 IL 的后处理则没有效果。ED 的诱导既不影响梗死面积,也不影响 IL 预处理的心脏保护作用。该方案允许在 CPLS 中研究 ED 下的心脏保护策略。IL 预处理的保护似乎独立于功能正常的内皮细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/8d17ccc7f328/ijms-25-10975-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/0b4b9b252c52/ijms-25-10975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/d53f59827928/ijms-25-10975-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/e4951181e5f7/ijms-25-10975-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/f7038452cf53/ijms-25-10975-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/4d21a4835823/ijms-25-10975-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/350012dd33bd/ijms-25-10975-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/8d17ccc7f328/ijms-25-10975-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/0b4b9b252c52/ijms-25-10975-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/d53f59827928/ijms-25-10975-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/e4951181e5f7/ijms-25-10975-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/f7038452cf53/ijms-25-10975-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/4d21a4835823/ijms-25-10975-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/350012dd33bd/ijms-25-10975-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bd/11507275/8d17ccc7f328/ijms-25-10975-g007.jpg

相似文献

1
Cardioprotection by Preconditioning with Intralipid Is Sustained in a Model of Endothelial Dysfunction for Isolated-Perfused Hearts.脂肪乳预处理对离体灌流心脏内皮功能障碍模型的心肌保护作用持续存在。
Int J Mol Sci. 2024 Oct 12;25(20):10975. doi: 10.3390/ijms252010975.
2
Dexmedetomidine preconditioning attenuates ischemia/reperfusion injury in isolated rat hearts with endothelial dysfunction.右美托咪定预处理减轻内皮功能障碍大鼠离体心脏缺血/再灌注损伤。
Biomed Pharmacother. 2019 Jun;114:108837. doi: 10.1016/j.biopha.2019.108837. Epub 2019 Apr 6.
3
Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.脂肪乳剂,一种临床安全的化合物,比环孢素 A 更有效地保护心脏免受缺血再灌注损伤。
Anesthesiology. 2012 Oct;117(4):836-46. doi: 10.1097/ALN.0b013e3182655e73.
4
The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases.英脱利匹特®介导的心脏保护作用机制:活性代谢产物棕榈酰肉碱抑制复合物IV,产生活性氧并激活再灌注损伤挽救激酶。
PLoS One. 2014 Jan 30;9(1):e87205. doi: 10.1371/journal.pone.0087205. eCollection 2014.
5
Cardioprotective Properties of Mannitol-Involvement of Mitochondrial Potassium Channels.甘露醇的心脏保护作用:涉及线粒体钾通道。
Int J Mol Sci. 2021 Feb 27;22(5):2395. doi: 10.3390/ijms22052395.
6
Phosphorylation of GSK-3β mediates intralipid-induced cardioprotection against ischemia/reperfusion injury.GSK-3β 的磷酸化介导脂肪乳剂诱导的缺血/再灌注损伤心肌保护作用。
Anesthesiology. 2011 Aug;115(2):242-53. doi: 10.1097/ALN.0b013e318223b8b9.
7
Lipid emulsion enhances cardiac performance after ischemia-reperfusion in isolated hearts from summer-active arctic ground squirrels.脂质乳剂可增强夏季活跃的北极地松鼠离体心脏缺血再灌注后的心脏功能。
J Comp Physiol B. 2017 Jul;187(5-6):715-724. doi: 10.1007/s00360-017-1071-z. Epub 2017 Mar 31.
8
Enhanced myocardial protection in cardiac donation after circulatory death using Intralipid postconditioning in a porcine model.使用脂肪乳剂后处理增强循环死亡后供心心肌保护的猪模型研究。
Can J Anaesth. 2019 Jun;66(6):672-685. doi: 10.1007/s12630-019-01322-x. Epub 2019 Feb 21.
9
Impact of Ca-Sensitive Potassium Channels in Levosimendan-Induced Postconditioning.左西孟旦诱导后处理中钙敏感受钾通道的作用。
Cardiovasc Drugs Ther. 2019 Oct;33(5):581-588. doi: 10.1007/s10557-019-06908-7.
10
Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.腺嘌呤核苷 A1 受体的激活可恢复高同型半胱氨酸血症大鼠心脏中缺血预处理抑制的心脏保护作用。
J Cardiovasc Pharmacol. 2009 Sep;54(3):204-12. doi: 10.1097/FJC.0b013e3181b04cc5.

本文引用的文献

1
Dysfunctional and Dysregulated Nitric Oxide Synthases in Cardiovascular Disease: Mechanisms and Therapeutic Potential.心血管疾病中功能失调和调控异常的一氧化氮合酶:机制与治疗潜力。
Int J Mol Sci. 2023 Oct 15;24(20):15200. doi: 10.3390/ijms242015200.
2
Endothelial dysfunction at the cellular level in three dimensions: severity, acuteness, and distribution.细胞层面的内皮功能障碍在三维空间中的严重程度、急性程度和分布情况。
Am J Physiol Heart Circ Physiol. 2023 Aug 1;325(2):H398-H413. doi: 10.1152/ajpheart.00256.2023. Epub 2023 Jun 30.
3
Cardioprotection and its Translation: A Need for New Paradigms? Or for New Pragmatism? An Opinionated Retro- and Perspective.
心脏保护及其翻译:需要新的范式?还是需要新的实用主义?有主见的回顾与展望。
J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231179613. doi: 10.1177/10742484231179613.
4
Function and Role of Histamine H Receptor in the Mammalian Heart.组胺H受体在哺乳动物心脏中的功能与作用
Pharmaceuticals (Basel). 2023 May 11;16(5):734. doi: 10.3390/ph16050734.
5
Quantitative aspects of nitric oxide production in the heart.心脏中一氧化氮生成的定量方面。
Mol Biol Rep. 2022 Nov;49(11):11113-11122. doi: 10.1007/s11033-022-07889-x. Epub 2022 Sep 15.
6
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
7
Perioperative Cardioprotection: General Mechanisms and Pharmacological Approaches.围术期心脏保护:一般机制和药理学方法。
Anesth Analg. 2020 Dec;131(6):1765-1780. doi: 10.1213/ANE.0000000000005243.
8
Dexmedetomidine Provides Cardioprotection During Early or Late Reperfusion Mediated by Different Mitochondrial K+-Channels.右美托咪定通过不同的线粒体 K+-通道在早期或晚期再灌注期间提供心脏保护。
Anesth Analg. 2021 Jan;132(1):253-260. doi: 10.1213/ANE.0000000000005148.
9
Oxytocin mediated cardioprotection is independent of coronary endothelial function in rats.催产素介导的心肌保护作用与大鼠冠状动脉内皮功能无关。
Peptides. 2020 Aug;130:170333. doi: 10.1016/j.peptides.2020.170333. Epub 2020 Jun 1.
10
Influence of Hyperglycemia on Dexmedetomidine-Induced Cardioprotection in the Isolated Perfused Rat Heart.高血糖对去甲肾上腺素诱导的离体灌注大鼠心脏心脏保护作用的影响。
J Clin Med. 2020 May 13;9(5):1445. doi: 10.3390/jcm9051445.